hsa-miR-1236-3p

ncRNA information

ncRNA name

hsa-miR-1236-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

TPT1

Cancer information

Cancer name

Lung Cancer

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-1236-3p could reverse DDP resistance by modulation of TPT1 gene and inhibition of Pim-3 signaling pathway in lung cancer cells.

Tissue resource

pairs of lung cancer tumor tissues and non-tumor adjacent tissues

human normal lung epithelial cell lines BESA-2B

lung cancer cell lines A549

Experiment

qRT-PCR,Luciferase reporter assay


Institute

Weifang Traditional Chinese Hospital

the Cell Bank of the Chinese Academy of Sciences

Country

China

Continent

Asia